According to Anebulo Pharmaceuticals latest financial reports the total liabilities of ANEB is $1.07M, an increase of 108.53% to 2022. At the end of 2022 company had $512.53K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Anebulo Pharmaceuticals is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $1.07M | 108.53% |
2022 | $512.53K | 112.11% |
2021 | $241.63K | -92.45% |
2020 | $3.20M | - |